Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
22.25
-0.89 (-3.85%)
Aug 12, 2026, 3:50 PM EDT - Market open
Caris Life Sciences Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Caris Life Sciences stock has a consensus rating of "Buy" and an average price target of $27. The average 1-year stock price forecast is 21.35% higher than the current stock price, while the lowest is $22 (-1.12%) and the highest is $36 (+61.80%).
Price Target: $27 (+21.35%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Caris Life Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 10 | 10 | 9 | 9 | 9 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 13 | 13 | 13 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Buy Reiterates $32 → $33 | Buy | Reiterates | $32 → $33 | +48.31% | Aug 7, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Aug 6, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Maintains $25 | Buy | Maintains | $25 | +12.36% | Aug 6, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $25 → $26 | Buy | Maintains | $25 → $26 | +16.85% | Aug 6, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $21 | Hold | Maintains | $21 | -5.62% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 812.03M
Increased by 27.00%
Revenue Next Year
1.21B
from 1.03B
Increased by 17.35%
EPS This Year
0.15
from -0.41
EPS Next Year
0.35
from 0.15
Increased by 141.02%
EPS and Forward PE are based on non-GAAP adjusted numbers.